M. Morganti

In Vitro Blood Compatibility of Novel Hydrophilic Chitosan Films for Vessel Regeneration and Repair

L. Ippolito, R. Bettini, S. Pipitone, 2013 .

Atherosclerosis and cancer: common pathways on the vascular endothelium.

A. Nicolini, C. Mittermayer, A. Carpi, 2002, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Von Willebrand's factor mediates the adherence of human tumoral cells to human endothelial cells and ticlopidine interferes with this effect.

A. Nicolini, C. Mittermayer, A. Carpi, 2000, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Plasmatic parameters of coagulation activation in thrombotic microangiopathy.

A. Nicolini, C. Mittermayer, A. Carpi, 1996, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Uremic medium increases cytokine-induced PAI-1 secretion by cultured endothelial cells.

A. Nicolini, C. Mittermayer, A. Cupisti, 1998, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Expression of tissue-type plasminogen activator, plasminogen activator inhibitor and von Willebrand factor in the supernatant of endothelial cell cultures in response to the seeding of adenocarcinoma cell line HRT-18.

C. Mittermayer, A. Carpi, M. Morganti, 1996, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

New Aspects of Peritoneal Pathology

K. Tory, C. Mittermayer, L. Tietze, 1997 .

Zoledronic acid determines S-phase arrest but fails to induce apoptosis in cholangiocarcinoma cells.

A. Romani, M. Morganti, A. Borghetti, 2009, Biochemical pharmacology.

p53alterations arepredictive ofchemoresistance and aggressiveness inovarian carcinomas: a molecularand immunohistochemical study

M. Morganti, 1997 .

Detection of minimal but significant amount of von Willebrand factor in human omentum mesothelial cell cultures.

C. Mittermayer, A. Carpi, M. Morganti, 1996, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Physicochemical and cell adhesion properties of chitosan films prepared from sugar and phosphate-containing solutions.

R. Bettini, A. Romani, M. Morganti, 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

The BH3-mimetic ABT-737 targets the apoptotic machinery in cholangiocarcinoma cell lines resulting in synergistic interactions with zoledronic acid

A. Romani, M. Morganti, M. C. Baroni, 2011, Cancer Chemotherapy and Pharmacology.

Multilayered chitosan scaffold for bile duct reconstruction

R. Tozzi, R. Bettini, A. Romani, 2008 .